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Furosemide-induced vasodilation: Importance of the state of hy-
dration and filtration. The circumstances under which furose-
mide increases renal blood flow was examined in mongrel dogs
as it may relate to a tubuloglomerular feedback mechanism. Two
maneuvers, desoxycorticosterone (DOCA) plus salt treatment
and inhibition of tubular fluid flow, were used in the dogs to eval-
uate the renal vascular effects of furosemide because these ma-
neuvers have been reported to blunt the tubuloglomerular feed-
back in micropuncture studies. In addition, we also used two
structurally different nonsteroidal antiinflammatory drugs to as-
sess the importance of prostaglandins to achieve furosemide's
renal vasodilation. Furosemide (5 mg/kg, i.v.) increased renal
blood flow in volume-depleted animals from a baseline flow of
141 28 mI/mm to a maximum of 176 35 mI/mm at 6 mm after
furosemide administration. If the animals were pretreated with a
high-salt diet and i.m. DOCA for 5 days, furosemide administra-
tion produced no renal vascular effects but still caused a large
diuresis, and these dogs still had a responsive renal vascular bed
to infused prostaglandin E2. In addition, kidneys rendered non-
filtering in volume-depleted animals had no renal vascular re-
sponse to furosemide. Volume-depleted animals, pretreated with
either indomethacin or sodium meclofenamate, did not have a
renal vascular response to furosemide although they did have a
diuretic response and a responsive renal vasculature to prosta-
glandin E2. From our data, we hypothesize that the renal vascu-
lar response to furosemide is secondary to a tubular mechanism
mediated by a vasodilatory prostaglandin. Because furosemide
has been shown to disrupt the tubuloglomerular feedback mecha-
nism, and the two maneuvers, DOCA plus salt treatment and
lack of filtration, blunt the tubuloglomerular feedback response
as well as inhibit the renal vascular response to furosemide, we
further hypothesize that furosemide-induced renal vasodilation
may be secondary to the disruption of an active tubuloglomerular
feedback mechanism.
Vasodilatation induite par le furosémide: Importance de l'état
d'hydratation et de filtration. Les circonstances oU le furosémide
augmente le debit sanguin renal ont été Ctudiees chez des chiens
bâtards en fonction d'un mécanisme possible de rétro-contrôle
tubulo-glomérulaire. Deux manoeuvres, le traitement par Ia des-
oxycorticostCrone (DOCA) et le sel et l'inhibition du debit tubu-
laire, ont été utilisées chez des chiens pour évaluer les effets
vasculaires rénaux du furosCmide, puisque ces deux manoeuvres
sont réputées effacer le rétro-contrôle tubulo-glomerulaire dans
les etudes par microponction. De plus, nous avons employe
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deux drogues anti-inflammatoires, non stéroidiennes, de struc-
tures differentes pour évaluer l'importance des prostaglandines
dans le déterminisme d'une vasodilatation rénale. Le furosémide
(5 mg/kg, i.v.) augmente Ic debit sanguin renal chez les animaux
deshydrates a partir d'une ligne debase de 141 28 mI/minjus-
qu'à un maximum de 176 35 mI/mm 6 minutes après
l'administration de furosémide. Quand les animaux ont été pré-
traités par une alimentation riche en sel et de Ia DOCA i.m.
pendant 5 jours l'administration de furosémide n'a pas produit
d'effets vasculaires rCnaux mais a cependant déterminé une diu-
rèse importante et le lit vasculaire renal de ces chiens pouvait
encore repondre a la perfusion de prostaglandines E2. De plus,
des reins devenus non filtrants chez des animaux deshydrates
n'avaient pas de reponse vasculaire rénale au furosémide. Les
animaux deshydratés et pré-traités soit par l'indométhacine, soit
par le meclofEnamate de sodium, n'avaient pas de réponse vas-
culaire rénale au furosémide quoiqu'ils avaient une réponse
diuretique et une réponse vasculaire rénale a Ia prostaglandine
E2. De ces résultats nous tirons l'hypothèse que la reponse vas-
culaire rénale au furosémide est secondaire a un mCcanisme
tubulaire dont Ia vasodilatation par la prostaglandine est un me-
diateur. Puisqu'il a été montré que le furosémide supprime Ic
rétro-contrôle tubulo-glomerulaire et que les deux manoeuvres,
DOCA et sel, d'une part, absence de filtration, d'autre part, an-
nulent le rétro-contrôle tubulo-glomérulaire de méme qu'elles
inhibent Ia réponse vasculaire rénale au furosémide, nous fai-
Sons l'hypothese supplementaire que la vasodilatation rénale in-
duite par le furosémide peut étre secondaire a l'interruption
d'un mécanisme actif de rétro-contrôle tubulo-glomerulaire.
Furosemide, a diuretic derived from anthranilic
acid, can increase renal blood flow and enhance re-
nal renin release [1, 2]. The mechanism by which
furosemide increases renal blood flow is unclear;
two theories can be proposed, however, from the
literature. One suggests that furosemide increases
renal prostaglandin production, which in turn re-
suits in an increased renal blood flow. This theory is
supported by the observation that indomethacin can
block the renal hemodynamic changes of furose-
mide [3]; but Duchin, Peterson, and Burke [4] have
failed to confirm these findings. The other theory
suggests that furosemide acts directly on vascular
smooth muscle to produce renal vasodilation [4-6].
It seems unlikely, however, that furosemide direct-
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ly affects vascular smooth muscle because not all
vascular beds respond qualitatively the same way
as the kidney [7, 8].
Another possible mechanism whereby furose-
mide could affect renal vascular resistance is
through interruption of the tubuloglomerular feed-
back mechanism. Recently, Briggs and Wright have
reported that the effector mechanism for the feed-
back control of the GFR in a single nephron is af-
ferent arteriole constriction [9]. Thus, interruption
of this pathway in all nephrons would result in af-
ferent arteriolar dilation with a resultant increase in
renal blood flow. Indeed, Wright and Schnermann
have reported that furosemide interferes with the
tubuloglomerular feedback mechanism in micro-
puncture experiments [10]. In addition, we have
evidence that the renal vasoconstriction produced
by an infusion of hypertonic saline into the renal
artery is somewhat analogous to the tubulo-
glomerular mechanism in isolated nephrons in-
asmuch as both are inhibited by the administration
of desoxycorticosterone (DOCA), furosemide, and
lack of filtration [11].
The current experiments were designed in dogs to
study the effect of hydration plus DOCA adminis-
tration and the lack of tubular fluid flow on the renal
vascular effects of furosemide. These experimental
circumstances were chosen because they have been
reported to blunt the tubuloglomerular feedback
mechanism in micropuncture experiments [12]. In
addition, we further explored the importance of
vasodilatory prostaglandins in mediating the de-
crease in vascular resistance produced by furose-
mide.
Methods
Twenty-two mongrel dogs of either sex weighing
18 to 30 kg were used to assess the renal hemo-
dynamic effects of furosemide (5 mg/kg, i.v.). The
dogs were divided into four experimental groups.
Group 1. Six mongrel dogs were acutely volume-
depleted by depriving them of food and water for 24
hours prior to the experiment. On the day of the
experiments, the dogs were anesthetized with pen-
tobarbital (30 mg/kg, i.v.) and respired using a posi-
tive pressure respiratory pump at a rate of 16
breaths/mm. A femoral artery was catheterized for
blood pressure monitoring, and a femoral vein was
catheterized for drug administration.
Through a midline abdominal incision, the left
renal artery was identified and cannulated with a 23-
guage needle for the infusion of hypertonic saline. A
noncannulating electromagnetic flow probe was
placed around the renal artery distal to the needle.
The left ureter was catheterized for urine collection.
After the animal had stabilized, hypertonic sodium
chloride, calculated to raise the renal arterial
plasma concentration of sodium by 30 mEq/liter,
was administered into the left renal artery for a total
of 10 mm, and the renal vasoconstrictor response
was determined. We have reported the analogy be-
tween this vasoconstrictor response in the whole
kidney, and the tubuloglomerular feedback mecha-
nism in micropuncture experiments because both
were inhibited by hydration plus DOCA, furose-
mide, and lack of tubular fluid flow [11]. When the
renal blood flow, urine flow, and blood pressure had
returned to baseline (usually 45 mm), furosemide (5
mg/kg, i.v.) was administered, and renal blood flow
and arterial blood pressure were monitored continu-
ously. Urine was collected for the first 15 mm after
furosemide and subsequently analyzed for sodium
and potassium by flame photometry.
Group 2. Five mongrel dogs were placed on diets
containing 250 mEq of sodium per day combined
with daily injections of 10 mg of desoxycorticoste-
rone (DOCA) for a total of 5 days prior to the exper-
iments. On the day of the experiment, the dogs
were fasted overnight, and given their DOCA injec-
tion early in the morning. The dogs were then surgi-
cally prepared identically to group 1 dogs. They too
underwent hypertonic saline infusion into the renal
artery as described with group 1 followed by i.v.
furosemide. The renal blood flow, arterial blood
pressure, and urinary output of sodium and potas-
sium were monitored before and after furosemide as
described before.
Group 3. Six mongrel dogs were dehydrated and
surgically prepared as described for dogs in group 1
except that these dogs were randomly assigned to
pretreatment with indomethacin (8 mg/kg, i.v.) or
sodium meclofenamate (10 mg/kg, i.v.) 30 mm prior
to the infusion of the hypertonic saline (three dogs
received indomethacin, and three dogs received
meclofenamate). The rest of the protocol was fol-
lowed as with the group 1 dogs with renal blood
flow, arterial blood pressure, and urinary output of
sodium and potassium monitored before and after
furosemide.
Group 4. Five mongrel dogs had one kidney ren-
dered nonfiltering by the procedure described by
Blame, Davis, and Witty [13]. The animals were al-
so acutely volume depleted as described in the pre-
vious sections. On the day of the experiment, the
animals were anesthetized with sodium pentobarbi-
tal (30 mg/kg, i.v.) and prepared surgically as de-
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Fig. 1. Effect offurosemide and intrarenal hypertonic saline on the renal blood flow in dehydrated animals. The open circle represents the
renal blood flow after furosemide administration, and the closed boxes represent renal blood flow after intrarenal hypertonic saline
infusion. The asterisk signifies that the change in renal blood flow is significantly different (P <0.05) from the control blood flow. The
zero value represents the control blood flow. Values represent the means 5EM (N = 6).
scribed for dogs in group 1. An electromagnetic
flow probe was placed around the renal artery of the
nonfiltering kidney, and renal blood flow was con-
tinuously monitored. The filtering kidney was surgi-
cally removed. These dogs were also given furose-
mide (5 mg/kg, i.v.). After the termination of the
experiments, 2 ml of indigo carmine was infused i.v.
to confirm that the kidney was nonfiltering.
Statistics. The renal hemodynamic data were an-
alyzed by Dunnett's t test, comparing control blood
flow with the multiple blood flow measurements af-
ter furosemide administration. A P value of less
than 0.05 was considered statistically significant.
Results
Group 1. Furosemide, in the volume-depleted an-
imals, significantly increased renal blood flow start-
ing at 3 mm after the drug administration and reach-
ing a maximum at 6 mm (Fig. 1). In these animals,
there was a significant decrease in renal blood flow
during the intrarenal infusion of hypertonic saline
infusion. Associated with furosemide's vasodila-
tion, there was a marked diuresis, natriuresis, and
kaliuresis (Table 1).
Group 2. In the salt-loaded and DOCA-treated
animals, furosemide had no renal vasodilating ef-
fect. There was a modest decrease in renal blood
flow at 1 mm but for the remaining 9 mm the renal
blood flow was not any different from baseline (Fig.
2). To document that the renal vasculature could
still respond to a vasodilatory stimulus, we infused
prostaglandins E2 (PGE2) at a dose of 100 ng/kg/min
into the renal artery, which resulted in a significant
increase in renal blood flow. In all these animals,
unlike in the volume-depleted animals, hypertonic
saline infusion into the renal artery produced only
increases in renal blood flow. Intravenous furose-
mide in all these animals also resulted in a marked
natriuresis (Table 1).
Group 3. Indomethacin and sodium meclofena-
mate did not interfere with the renal vasoconstric-
tion produced by an intrarenal infusion of hyper-
tonic saline in these volume-depleted animals; these
prostaglandin synthesis inhibitors, however, com-
pletely blocked the renal vascular effects of furose-
mide (Fig. 3). The kidneys still had a responsive
vasculature after the administration of the non-
steroidal antiinflammatory drugs, as seen by the
Table 1. The effect of furosemide (F) on urinary sodium and potassium excretiona
Volume, mi/mm Sodium, p.Eq/min Potassium , p.Eq/min
Before F After F Before F After F Before F After F
Dehydrated dogs (N= 6) 0.11 0.04 3.7 0.58' 17 5 468 53d 21 7 104 13C
DOCA + salt-treated dogs (N = 5) 0.73 0.22 5.7 l.7 156 68 936 268b 25 5 102 20b
NSAI(meclo-orindo-treateddehydrateddogs) 0.05 0.01 1.1 0.3 8 3 196 35c 4 74 18C
a Values are the means SEM. Abbreviations used are DOCA, desoxycorticosterone; NSAI, nonsteroidal antiinflammatory drugs;
meclo, sodium meclofenamate; indo, indomethacin.
b P < 0.05.
'P <0.01.p < 0.001.
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large increase in renal blood flow produced by intra-
renal POE2 infusion (100 ng/kgfmin). The non-
steroidal antiinflammatory drugs altered the diuretic
effect of furosemide very little (Table 1).
Furosemide did not produce renal vascular
changes in the nonfiltering kidneys of volume-de-
pleted dogs (Fig. 4). In none of the animals did fu-
rosemide produce consistent effects on arterial
pressure (Table 2).
Discussion
Although the renal vasoactivity of furosemide
was described over a decade ago, the exact mecha-
nism of this vasodilation is still unknown, It is clear
that not all investigators have found that furosemide
increases renal blood flow, and not all vascular beds
respond to furosemide in the same manner as the
renal vasculature [7, 8, 14, 15]. These findings prob-
ably indicate that the renal vasodilation is not a di-
rect effect of furosemide on vascular smooth muscle
and that the vascular response occurs only under
certain circumstances. Our present data show that
the renal vascular effect of furosemide requires
prostaglandin synthesis and renal tubular fluid flow,
and that the vascular response to furosemide is in-
hibited by pretreatment with DOCA and salt, a ma-
neuver that does not block the renal vasodilator re-
sponse to POE2.
Data from micropuncture experiments indicate
that the renal tubule can control renal afferent arte-
riolar tone through a feedback mechanism, and fu-
rosemide can interrupt this mechanism [9, 10]. We
Furosemide renal vasodilation 457
5 6 PGE2
300
200
100
Time, rn/n infusion
Fig. 2. Effect offurosemide and intrarenal hypertonic saline on the renal blood flow in salt-loaded and DOCA-treated dogs. The open
circle represents the renal blood flow after furosemide administration, and the closed box represents renal blood flow after intrarenal
hypertonic saline infusion. The asterisk signifies that the change in renal blood flow is significantly different (P < 0.05) from the control
blood flow. Prostaglandin E2 was administered intrarenally to assess whether the renal vascular bed was responsive to vasodilatory
prostaglandin stimulus. Values represent means SEM (N = 5).
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Fig. 3. Effect offurosemide and intrarenal hypertonic saline on the renal blood flow in prostaglandin-inhibited animals. The open circle
represents renal blood flow after furosemide administration, and the closed box represents renal blood flow after intrarenal hypertonic
saline infusion. The asterisk signifies that the change in renal blood flow is significantly different (P < 0.05) from the control blood flow.
Prostaglandin E2 was administered intrarenally to assess whether the renal vascular bed could respond to a vasodilatory prostaglandin
stimulus. Values represent means SEM (N = 6).
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Table 2. Blood pressure effects of furosemide (in mm Flg)a
Dehydrated dogs(N = 6)
DOCA + salt
(N = 5)
NSAI-treated, dehydrated(N = 6)
Nonfiltering, dehydrated(N = 5)
BeforeF 135±4 136±3 120±7 123±4
AfterF 130 3 135 3 121 7 123 3
a Values are the means SEM. Abbreviations are defined in Table 1. None of the changes was statistically significant.
postulate that the furosemide increases renal blood
flow in the whole kidney by a similar mechanism,
that is, by interruption of a tubuloglomerular feed-
back. Our data support this hypothesis because the
two maneuvers, volume expansion plus DOCA and
the lack of renal tubular fluid movement, not only
inhibited furosemide's renal vascular effect in our
experiments but also are known to blunt the tubulo-
glomerular feedback mechanism. In addition, all the
diuretics that act like furosemide to inhibit ion
transport in the ioop of Henle have been reported to
produce renal vasodilation. Thiazide diuretics that
inhibit ion transport beyond the ioop of Henle do
not decrease renal vascular resistance [16].
Our proposal that furosemide vasodilates the kid-
ney through the inhibition of the tubuloglomerular
feedback is purely deductive because we have no
micropuncture evidence that we are, indeed, inhib-
iting the tubuloglomerular feedback mechanism by
furosemide. The parallel conditions of inhibition in
our study and those described in the micropuncture
literature suggest, however, that furosemide's vas-
cular effects are through a tubular rather than a di-
rect vascular mechanism. It is of interest that an in-
fusion of hypertonic saline into the renal artery pro-
duced renal vasoconstriction only in those animals
that also had a renal vasodilator response to furose-
mide. The renal vascular response to hypertonic sa-
0 5
Time, mm
Fig. 4. Effect offurosemide on renal blood flow in animals with a
single nonfiltering kidney (., N= 5). Values represent means
SEM.
line also shows similarities to the activation of a
tubuloglomerular feedback in that it is inhibited by
DOCA-salt treatment and by furosemide [11]. Al-
though most of the literature dealing with the
tubuloglomerular feedback mechanism is in rats,
Navar et al have shown in micropuncture studies
that dogs also have an active tubuloglomerular feed-
back mechanism [17].
The mediator for the renal vasodilation following
furosemide administration is a prostaglandin be-
cause two structurally dissimilar inhibitors of pros-
taglandin synthesis were equally proficient in inhib-
iting this vascular response. These findings are in
agreement with Bailie, Barbour, and Hook [3] and
Data et al [18] but are in disagreement with Duchin,
Peterson, and Burke [4]. The discrepancy between
our findings and the findings of Duchin et al is not
readily explicable, but it is clear from our data that
the nonsteroidal antiinflammatory drugs did not al-
ter renal vascular responsiveness because the kid-
ney still vasodilated to PGE2. The data also agree
with Bailie, Crosslan, and Hook [19] that prosta-
glandin inhibition does not alter the diuretic re-
sponse to furosemide; therefore furosemide's di-
uretic effect is neither prostaglandin nor hemo-
dynamically mediated.
If our hypothesis that furosemide produces renal
vasodilation by interrupting an active tubulo-
glomerular feedback is corroborated by micro-
puncture experiments, we would predict that all
drugs and interventions that inhibit the tubulo-
glomerular feedback mechanism should inhibit fu-
rosemide's vascular effect as well. Such studies
should help to reconcile the reported discrepancies
in the literature regarding the vascular effects of fu-
rosemide.
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